Bryce Kanter
VP, Commercial @Clarity Pharmaceuticals
Signup · Get unlimited contacts
WORK HISTORY
VP, Commercial @Clarity Pharmaceuticals
US
Commercial strategy lead for Clarity’s diagnostic and therapeutic radiopharmaceutical pipeline, primarily focused on 64Cu-SAR-bisPSMA (diagnostic) and 67Cu-SAR-bisPSMA (therapeutic) in prostate cancer• Established cross-functional launch team for 64Cu-SAR-bisPSMA (diagnostic) and built out launch plans, budgets and headcounts in partnership with each function lead• Managed market research, competitive intelligence and forecasting activities for Clarity’s pipeline to provide commercial perspective to senior executive team and inform clinical development and asset strategies• Supported R&D and clinical development on pipeline target selection and prioritization based on future market potential and dynamics, including the development of target product profiles• Represented Clarity at scientific and industry meetings, including panel and speaking opportunities at Oppenheimer’s Radiopharmaceutical Conference and Targeted Radiopharmaceuticals (TRP) Supply Chain and Manufacturing Summit• Build relationships and advocacy for Clarity’s Targeted Copper Theranositc Platform through KOL relationships and key programs with industry partners
EDUCATION
Gonzaga University
Bachelor's Degree, Biochemistry
Rutgers Graduate School of Biomedical and Health Sciences
Master of Science (M.S.) in Biomedical Sciences
Rutgers Business School
Master of Business Administration (M.B.A.), Pharmaceutical Marketing and Management
SKILLS
ABOUT BRYCE KANTER
Commercial oncology leader with a passion for building teams and translating marketing strategies into initiatives that drive the brand’s success through the influence of cross-functional teams and relationships with key customers. Proven track record of managing launch complexity and developing innovative commercial solutions for complex radiopharmaceutical platforms in oncology. Career Summary & Highlights:• 10+ years of commercial biotech and pharmaceutical experience with 6+ years in US brand marketing for radiopharmaceutical platforms in oncology• Launched 2 blockbuster therapeutics (Nubeqa and Pluvicto) and 1 diagnostic (Locametz) in prostate cancer• Marketed 3 complex therapeutic platforms: Pluvicto/Locametz, Xofigo and Betaseron/Betaconnect • Experienced cross-functional and commercial launch team leader• MBA in Marketing & Pharmaceutical Management; MS in Biomedical Sciences; BS in Biochemistry
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.